CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 03:50PM GMT
Release Date Price: R$40.69 (-3.20%)
Lisa Christine Gill
JPMorgan Chase & Co, Research Division - MD, Head of U.S. Healthcare Technology & Distribution Equity Research and Senior Research Analyst

Good morning. My name is Lisa Gill, and I'm a health care services analyst with JPMorgan. It is with great pleasure this morning that I introduce CVS Health.

With us this morning, we have Karen Lynch, incoming CEO; Larry Merlo, outgoing CEO; and CFO, Eva Boratto. Larry and Eva will join us for the Q&A session that we will begin right after Karen makes some opening comments. So welcome, Karen, and I'm going to hand it off to you.

Karen Lynch

Good morning, Lisa, it's nice to see you. Good morning, everyone. Larry, Eva and I are looking forward to today's discussion. But before we begin, I'd like to remind everyone that we're going to make some forward-looking statements today that are subject to risks and uncertainties. And I'll direct you to the full statement that we have included on your screen right now.

At CVS Health, our transformation over the last decade has enabled us to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot